A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222
Public ClinicalTrials.gov record NCT03969888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 in Cystic Fibrosis Subjects Who Are Homozygous for the F508del Mutation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety, tolerability, and efficacy of ABBV-3067 given alone and in combination with various doses of ABBV-2222 in adults with Cystic Fibrosis who are homozygous for the F508del mutation.
Study identification
- NCT ID
- NCT03969888
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 10, 2019
- Primary completion
- Jun 8, 2022
- Completion
- Jun 8, 2022
- Last update posted
- Jun 27, 2023
2019 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas /ID# 212541 | Little Rock | Arkansas | 72205 | — |
| Tampa General Hospital /ID# 212342 | Tampa | Florida | 33606 | — |
| University of Iowa Hospitals and Clinics /ID# 212351 | Iowa City | Iowa | 52242 | — |
| Univ Michigan Med Ctr /ID# 212657 | Ann Arbor | Michigan | 48109 | — |
| Cardinal Glennon Children's Hospital /ID# 212349 | St Louis | Missouri | 63104 | — |
| Washington University-School of Medicine /ID# 212352 | St Louis | Missouri | 63110 | — |
| Nationwide Children's Hospital /ID# 213158 | Columbus | Ohio | 43205-2664 | — |
| Medical University of South Carolina /ID# 212187 | Charleston | South Carolina | 29425 | — |
| Vanderbilt University Medical Center /ID# 212353 | Nashville | Tennessee | 37232 | — |
| University of Utah /ID# 212350 | Salt Lake City | Utah | 84112-5500 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03969888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2023 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03969888 live on ClinicalTrials.gov.